RPS3AP13

Across TCGA pan-cancer cohorts, RPS3AP13 RNA differs between tumor and matched normal tissue in 7 of 18 cancer types tested, making tumor–normal expression one of RPS3AP13’s most consistent transcriptional readouts.

The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where RPS3AP13 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RPS3AP13 is over-expressed in tumor, although a few such as THCA and KICH show the opposite, repressed pattern.

LIHC, THCA, and KICH are the cancer types where RPS3AP13 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RPS3AP13 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LIHC	Female	II,III,IV	+0.153	<.001	9	view →
THCA	All	All	−0.146	.001	9	view →
KICH	All	All	−0.174	<.001	4	view →
BRCA	All	All	+0.118	.005	4	view →
LUAD	Male	All	+0.238	.029	1	view →
LUAD	Female	II,III,IV	−0.204	.012	1	view →
BLCA	Female	III,IV	+0.172	.039	1	view →
KIRC	All	All	+0.079	.018	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 8 strongest of 7 lineages.

RPS3AP13–LIHC

Open the LIHC breakdown →